| Regional nodal irradiation in early-stage breast cancer TJ Whelan, IA Olivotto, WR Parulekar, I Ackerman, BH Chua, A Nabid, ... New England Journal of Medicine 373 (4), 307-316, 2015 | 1283 | 2015 |
| Targeting ATR in vivo using the novel inhibitor VE-822 results in selective sensitization of pancreatic tumors to radiation E Fokas, R Prevo, JR Pollard, PM Reaper, PA Charlton, B Cornelissen, ... Cell death & disease 3 (12), e441-e441, 2012 | 448 | 2012 |
| NCIC-CTG MA. 20: an intergroup trial of regional nodal irradiation in early breast cancer. TJ Whelan, I Olivotto, I Ackerman, JW Chapman, B Chua, A Nabid, ... Journal of clinical oncology 29 (18_suppl), LBA1003-LBA1003, 2011 | 352 | 2011 |
| 111In-labeled trastuzumab (Herceptin) modified with nuclear localization sequences (NLS): an Auger electron-emitting radiotherapeutic agent for HER2/neu-amplified breast cancer DL Costantini, C Chan, Z Cai, KA Vallis, RM Reilly Journal of Nuclear Medicine 48 (8), 1357-1368, 2007 | 221 | 2007 |
| Assessment of coronary heart disease morbidity and mortality after radiation therapy for early breast cancer KA Vallis, M Pintilie, N Chong, E Holowaty, PS Douglas, P Kirkbride, ... Journal of clinical oncology 20 (4), 1036-1042, 2002 | 216 | 2002 |
| 111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR RM Reilly, R Kiarash, RG Cameron, N Porlier, J Sandhu, RP Hill, K Vallis, ... Journal of Nuclear Medicine 41 (3), 429-438, 2000 | 192 | 2000 |
| Applications and limitations of machine learning in radiation oncology D Jarrett, E Stride, K Vallis, MJ Gooding The British journal of radiology 92 (1100), 20190001, 2019 | 160 | 2019 |
| A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer RM Reilly, R Kiarash, J Sandhu, YW Lee, RG Cameron, A Hendler, ... Journal of Nuclear Medicine 41 (5), 903-911, 2000 | 158 | 2000 |
| Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibility CR Wolf, CAD Smith, AC Gough, JE Moss, KA Vallis, G Howard, FJ Carey, ... Carcinogenesis 13 (6), 1035-1038, 1992 | 154 | 1992 |
| Targeted radionuclide therapy in combined-modality regimens MR Gill, N Falzone, Y Du, KA Vallis The Lancet Oncology 18 (7), e414-e423, 2017 | 140 | 2017 |
| Cone beam computed tomography guidance for setup of patients receiving accelerated partial breast irradiation EA White, J Cho, KA Vallis, MB Sharpe, G Lee, H Blackburn, T Nageeti, ... International Journal of Radiation Oncology* Biology* Physics 68 (2), 547-554, 2007 | 132 | 2007 |
| A population-based case-cohort study of the risk of myocardial infarction following radiation therapy for breast cancer LF Paszat, KA Vallis, VMA Benk, PA Groome, WJ Mackillop, A Wielgosz Radiotherapy and Oncology 82 (3), 294-300, 2007 | 121 | 2007 |
| Proteomic analyses reveal high expression of decorin and endoplasmin (HSP90B1) are associated with breast cancer metastasis and decreased survival TR Cawthorn, JC Moreno, M Dharsee, D Tran-Thanh, S Ackloo, PH Zhu, ... PloS one 7 (2), e30992, 2012 | 113 | 2012 |
| Transition metal compounds as cancer radiosensitizers MR Gill, KA Vallis Chemical Society Reviews 48 (2), 540-557, 2019 | 107 | 2019 |
| Selective permeabilization of the blood–brain barrier at sites of metastasis JJ Connell, G Chatain, B Cornelissen, KA Vallis, A Hamilton, L Seymour, ... Journal of the national cancer institute 105 (21), 1634-1643, 2013 | 99 | 2013 |
| Computational analysis of the number, area and density of γ-H2AX foci in breast cancer cells exposed to 111In-DTPA-hEGF or γ-rays using Image-J software Z Cai, KA Vallis, RM Reilly International journal of radiation biology 85 (3), 262-271, 2009 | 99 | 2009 |
| Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human … P Chen, R Cameron, J Wang, KA Vallis, RM Reilly Journal of nuclear medicine 44 (9), 1469-1478, 2003 | 98 | 2003 |
| Trastuzumab-resistant breast cancer cells remain sensitive to the auger electron–emitting radiotherapeutic agent 111In-NLS-trastuzumab and are radiosensitized by methotrexate DL Costantini, K Bateman, K McLarty, KA Vallis, RM Reilly Journal of Nuclear Medicine 49 (9), 1498-1505, 2008 | 96 | 2008 |
| Nanographene oxide-based radioimmunoconstructs for in vivo targeting and SPECT imaging of HER2-positive tumors B Cornelissen, S Able, V Kersemans, PA Waghorn, S Myhra, K Jurkshat, ... Biomaterials 34 (4), 1146-1154, 2013 | 92 | 2013 |
| XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer Patients P Seibold, S Behrens, P Schmezer, I Helmbold, G Barnett, C Coles, ... International Journal of Radiation Oncology* Biology* Physics 92 (5), 1084-1092, 2015 | 90 | 2015 |
